Clinical Trial Update: Effect of Methotrexate Carried by a Lipid Nanoemulsion on Left Ventricular Remodeling After STEMI [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating methotrexate delivered via lipid nanoemulsion for effects on left ventricular remodeling after anterior wall myocardial infarction; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Remodeling
• Myocardial Infarction
• Myocardial Remodeling Ventricular

Drugs mentioned

• Methotrexate carried by a lipid nanoemulsion (Methotrexate)

Snippet

Sponsor: University of Sao Paulo | Conditions: Myocardial Infarction, Anterior Wall, Myocardial Remodeling, Ventricular | Phase 2, Phase 3 | Status: TERMINATED